Authors:
Zorn, E
Orsini, E
Wu, CJ
Stein, B
Chillemi, A
Canning, C
Alyea, EP
Soiffer, RJ
Ritz, J
Citation: E. Zorn et al., A CD4+T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells, TRANSPLANT, 71(8), 2001, pp. 1131-1137
Authors:
Yang, XF
Wu, CJ
McLaughlin, S
Chillemi, A
Wang, KS
Canning, C
Alyea, EP
Kantoff, P
Soiffer, RJ
Dranoff, G
Ritz, J
Citation: Xf. Yang et al., CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia, P NAS US, 98(13), 2001, pp. 7492-7497
Authors:
Alyea, E
Weller, E
Schlossman, R
Canning, C
Webb, I
Doss, D
Mauch, P
Marcus, K
Fisher, D
Freeman, A
Parikh, B
Gribben, J
Soiffer, R
Ritz, J
Anderson, K
Citation: E. Alyea et al., T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect, BLOOD, 98(4), 2001, pp. 934-939
Authors:
Hochberg, EP
Chillemi, AC
Wu, CJ
Neuberg, D
Canning, C
Hartman, K
Alyea, EP
Soiffer, RJ
Kalams, SA
Ritz, J
Citation: Ep. Hochberg et al., Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults, BLOOD, 98(4), 2001, pp. 1116-1121
Authors:
Orsini, E
Alyea, EP
Chillemi, A
Schlossman, R
McLaughlin, S
Canning, C
Soiffer, RJ
Anderson, KC
Ritz, J
Citation: E. Orsini et al., Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma, BIOL BLOOD, 6(4), 2000, pp. 375-386
Authors:
Orsini, E
Alyea, EP
Schlossman, R
Canning, C
Soiffer, RJ
Chillemi, A
Neuberg, D
Anderson, KC
Ritz, J
Citation: E. Orsini et al., Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion, BONE MAR TR, 25(6), 2000, pp. 623-632
Authors:
Davies, R
Brailsford, S
Roderick, P
Canning, C
Crabbe, D
Citation: R. Davies et al., Using simulation modelling for evaluating screening services for diabetic retinopathy, J OPER RES, 51(4), 2000, pp. 476-484
Authors:
Wu, CJ
Yang, XF
McLaughlin, S
Neuberg, D
Canning, C
Stein, B
Alyea, EP
Soiffer, RJ
Dranoff, G
Ritz, J
Citation: Cj. Wu et al., Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia, J CLIN INV, 106(5), 2000, pp. 705-714
Authors:
Sehn, LH
Alyea, EP
Weller, E
Canning, C
Lee, S
Ritz, J
Antin, JH
Soiffer, RJ
Citation: Lh. Sehn et al., Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneicbone marrow transplantation for chronic myelogenous leukemia: Impact of donor lymphocyte infusion, J CL ONCOL, 17(2), 1999, pp. 561-568
Authors:
Choo, PW
Rand, CS
Inui, TS
Lee, MLT
Cain, E
Cordeiro-Breault, M
Canning, C
Platt, R
Citation: Pw. Choo et al., Validation of patient reports, automated pharmacy records, and pill countswith electronic monitoring of adherence to antihypertensive therapy, MED CARE, 37(9), 1999, pp. 846-857